These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 25758165)
21. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064 [TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846 [TBL] [Abstract][Full Text] [Related]
24. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619 [TBL] [Abstract][Full Text] [Related]
25. miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma. Chen S; Li F; Chai H; Tao X; Wang H; Ji A Biochem Biophys Res Commun; 2015 Aug; 464(2):500-5. PubMed ID: 26163264 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183 [TBL] [Abstract][Full Text] [Related]
28. Cholesterol-conjugated let-7a mimics: antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy. Liu YM; Xia Y; Dai W; Han HY; Dong YX; Cai J; Zeng X; Luo FY; Yang T; Li YZ; Chen J; Guan J BMC Cancer; 2014 Nov; 14():889. PubMed ID: 25429777 [TBL] [Abstract][Full Text] [Related]
29. Double-negative feedback loop between microRNA-422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis. Zhang J; Yang Y; Yang T; Yuan S; Wang R; Pan Z; Yang Y; Huang G; Gu F; Jiang B; Lin C; Zhou W Hepatology; 2015 Feb; 61(2):561-73. PubMed ID: 25251503 [TBL] [Abstract][Full Text] [Related]
30. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745 [TBL] [Abstract][Full Text] [Related]
31. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Varshney A; Panda JJ; Singh AK; Yadav N; Bihari C; Biswas S; Sarin SK; Chauhan VS Hepatology; 2018 Apr; 67(4):1392-1407. PubMed ID: 29108133 [TBL] [Abstract][Full Text] [Related]
32. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14. Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355 [TBL] [Abstract][Full Text] [Related]
33. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766 [TBL] [Abstract][Full Text] [Related]
34. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1. Qin J; Luo M; Qian H; Chen W Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717 [TBL] [Abstract][Full Text] [Related]
35. The altered microRNA profile in andrographolide-induced inhibition of hepatoma tumor growth. Lu B; Sheng Y; Zhang J; Zheng Z; Ji L Gene; 2016 Aug; 588(2):124-33. PubMed ID: 27182051 [TBL] [Abstract][Full Text] [Related]
36. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863 [TBL] [Abstract][Full Text] [Related]
37. A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma. Zhang Y; Guo X; Li Z; Li B; Li Z; Li R; Guo Q; Xiong L; Yu L; Zhao J; Lin N RNA Biol; 2015; 12(6):643-57. PubMed ID: 25985117 [TBL] [Abstract][Full Text] [Related]
38. Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis. Wani NA; Zhang B; Teng KY; Barajas JM; Motiwala T; Hu P; Yu L; Brüschweiler R; Ghoshal K; Jacob ST Mol Cancer Res; 2018 Feb; 16(2):256-268. PubMed ID: 29187559 [TBL] [Abstract][Full Text] [Related]
39. Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development. Pu W; Li J; Zheng Y; Shen X; Fan X; Zhou JK; He J; Deng Y; Liu X; Wang C; Yang S; Chen Q; Liu L; Zhang G; Wei YQ; Peng Y Hepatology; 2018 Aug; 68(2):547-560. PubMed ID: 29381806 [TBL] [Abstract][Full Text] [Related]
40. Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression. Youness RA; Rahmoon MA; Assal RA; Gomaa AI; Hamza MT; Waked I; El Tayebi HM; Abdelaziz AI Growth Factors; 2016 Aug; 34(3-4):128-40. PubMed ID: 27388576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]